In contrast, other NOS2 variants in the promoter region that favor reduced NO bioavailability in absence of infection (e.g., rs8078340) were underrepresented in individuals with lower markers of exposure to pre-erythrocytic infection (e.g., anti-CSP antibodies) suggesting they contribute to resistance to infection (117). Here, NOS2 is linked to infection.